A study published March 5 in a Cell Press journal identifies a previously unknown route by which toxic tau protein is cleared from the brain, and a cell type few outside neuroscience have heard of appears to be doing the work. Tanycytes, non-neuronal cells found mainly in the third ventricle, carry harmful molecules out of the cerebrospinal fluid and into the bloodstream for disposal. When those cells stop functioning properly, tau accumulates in the brain.
Tau build-up is one of the defining features of Alzheimer's disease, and most research attention has gone to how tau is produced, modified, and spread between neurons. This work shifts part of the focus to disposal, and to a cell type previously studied mainly for its role in shuttling metabolic signals between the blood and the cerebrospinal fluid, the liquid that surrounds the brain and spinal cord and helps maintain homeostasis.
The researchers describe the finding as revealing a previously underappreciated, disease-relevant role for tanycytes in neurodegeneration, and suggest that supporting tanycyte health could be one way to improve tau clearance and slow disease progression. That framing matters because it points toward a therapeutic target outside the neuron itself.
The team drew on animal and cellular models along with human patient tissue, which strengthens the case that the mechanism is relevant to the disease and not an artifact of one experimental system. Whether tanycyte function can actually be restored or boosted in people, and whether doing so measurably changes tau levels, remains to be worked out.